Connect with us

Magazine

Canadian Artist JayHonest Turning Pain into Power

JayHonest

 

In the ever-evolving world of music, few artists manage to carve out a space that feels uniquely their own. JayHonest, born Jordan Jason Poirier Whelan in Ottawa, Canada, is one of those rare talents. With a story rooted in resilience and a passion for music that began in childhood, JayHonest is making waves in the industry, one heartfelt lyric at a time.

Growing up in Ottawa, Jay’s early life was far from easy. Born at the Children’s Hospital of Eastern Ontario (CHEO) in 1994, he faced challenges that would shape his journey. His mother’s illness kept her bedridden for five years, his father was in and out of his life, and his overachieving sister often overshadowed him. Despite these struggles, Jay found solace in music. By the age of six, he was already writing lyrics, and by 15, he was performing at Ottawa’s first CapCityShowdown, where he became the only contestant to receive an encore from the crowd.

Today, JayHonest is not just a recording artist but also the CEO and manager of his label, HONESTGANG. He’s dedicated to helping other artists achieve their dreams while continuing to build his legacy. In a recent interview with Honk Magazine, Jay opened up about his journey, struggles, and vision for the future.


Jay’s music is deeply personal, often reflecting his pain and challenges. “Growing up, I had a pretty traumatic childhood, filled with abuse, fake love, no support, and false hope,” he shared. “I made it my mission to give myself a voice, so maybe one day, my pain can help someone else in life.” This raw honesty resonates with his fans, who often connect with the vulnerability in his lyrics.

Breaking into the music industry wasn’t easy. Jay faced numerous obstacles, including a lack of support from his hometown. “Being from Canada, in the capital, there isn’t much support for music,” he explained. “When you excel and don’t stick around the underground scene, you get shunned.” To overcome this, Jay shifted his focus to international markets, particularly the USA and Europe, which helped kickstart his career.

Advertisement

Jay’s single New Year’s marked a turning point in his career. While it wasn’t his first release or favorite, it was the first to gain significant attention, surpassing 100,000 streams. This milestone also boosted his earlier single, The Call, which hit the same mark shortly after. However, Superstar, produced by ForeignGotEm, truly propelled him into the spotlight.

When asked about his reaction to the song’s success, Jay admitted, “I just knew I could do better and made a promise that in 2020, I would go 10x harder. I just want more!” This relentless drive is a hallmark of Jay’s work ethic and ambition.

Jay’s versatility as an artist is evident in his collaborations. While he listens to mainstream artists like Rich The Kid, Tyga, and A Boogie Wit Da Hoodie, he’s worked with various talents, including Arty Warhol, OT Benzz, Papi AQ, and Shiloh Dynasty. With over 10 new collaborations lined up for 2020, including projects with Sheddy Empire, Tribe Mafia, and Breanna Marin, Jay is poised to expand his reach even further.

Despite his growing success, Jay remains hands-on in every aspect of his career. He’s a true DIY artist, from mixing and mastering to promotion, video directing, and tour management. “I learn how to do it, and I do it,” he said proudly.

For Jay, the best part of his career is the freedom it brings. “I have seven days a week to plan out what I want to do. Being able to wake up anytime you want and hit record is a beautiful feeling,” he shared. However, he acknowledges the loneliness that comes with the territory. “It’s quite a lonely life. Most of my clients and relationships are online, and the bigger you get, the more careful you have to be about who you let in.”

Advertisement

When asked if he’s addicted to anything, Jay’s answer was simple yet powerful: “Success. I’m addicted to the growth. Seeing fans’ expressions when I drop a meaningful song, like my debut album, is amazing. It always makes me want more.”

As JayHonest continues to rise, his story is a testament to the power of perseverance and passion. With his eyes set on even greater heights, 2020 is shaping up to be the year JayHonest truly becomes a household name. Keep an eye on this Canadian artist—his journey is just beginning.

 

Celebrity

The Shocking Net Worth of Kendrick Lamar in 2025 (Updated)

Kendrick Lamar - net worth 2025

Kendrick Lamar is a Pulitzer Prize-winning rapper and lyrical genius who has taken the music industry by over a decade. Lamar’s reach goes far beyond hip-hop, from his game-changing albums to multimillion-dollar brand partnerships. But just how much is the DAMN. What is a rapper worth in 2025? The numbers are simply mind-blowing.

Industry insiders estimate Kendrick Lamar’s 2025 net worth is between 150 million and 180 million dollars. His financial empire grows with profitable album sales, global sold-out tours, and smart business decisions. Check out this article on Kendrick Lamar’s “Not Like Us,” which Dominates Spotify’s Global Chart for the Ninth Consecutive Day.

Lamar’s wealth is not merely from album sales and streaming. His wealth comes from several income streams, including:

Music Catalog & Royalties — With legendary albums like a good kid, m.A.A.d City, To Pimp a Butterfly, and DAMN. Kendrick Lamar still makes millions from streaming services, vinyl records, and radio plays.

Concerts & Live Performances — Kendrick’s last world tour grossed over $100 million, while show ticket prices have been high partly because of high demand.

Advertisement

pgLang Empire — His creative agency, pgLang, is a major creative force through which he produces music, film, and brand partnerships.

Brand Éndorsements & Partnerships—Lamar has signed endorsement deals with behemoths like Nike, Cash App, and luxury fashion houses, earning millions a year.

Investments & Business Ventures—Besides music, the Compton-born rapper has invested in real estate, tech startups, and cryptocurrency, diversifying his wealth.

How Much Kendrick Lamar Makes Per Year

Industry analysts estimate Kendrick Lamar earns from $25 million to $40 million yearly in all revenue streams. With streaming still booming, touring emerging as a primary driver of income, and pgLang expanding, Lamar’s income has no signs of slowing down.

Advertisement

Will Kendrick Lamar Be a Billionaire? Given his shrewd financial decisions and significant presence in the entertainment and business sectors, people in the know anticipate that Kendrick Lamar is approaching billionaire status. Not quite yet, but with a trajectory that looks distinctly like a future opportunity to join the billion-dollar club alongside Jay-Z and Kanye West, it isn’t out of the question within the next few years.

Kendrick Lamar’s money reflects his talent, business savvy, and cultural influence. From a small-time lyricist in Compton to one of the wealthiest and most respected artists, he has come a long way and has an inspirational story.

As the world anticipates his next chapter, maybe a new album, another monumental tour, or yet another disruptive business move one thing is sure his influence, artistically and financially, is only growing.

Continue Reading

Magazine

Why bioaccess™ is the Ideal Partner for Medtech Clinical Trials

In medical technology, the importance of clinical trials cannot be overstated. These trials serve as crucial stages in the development and validation of new medical devices, ensuring their safety, effectiveness, and regulatory compliance before they reach the market. While clinical trials are conducted worldwide, bioaccess™ has emerged as a particularly attractive partner for Medtech companies seeking to accelerate their research and development efforts. Let’s explore why bioaccess™ stands out as the ideal partner for Medtech clinical trials.

Diverse Patient Populations

bioaccess™ boasts a network of diverse patient populations with varying demographics, ethnicities, and medical backgrounds. This diversity is invaluable in clinical research, as it allows for a more comprehensive assessment of a medical device’s performance across different groups. Medtech companies partnering with bioaccess™ can gather data from a broad spectrum of patients, enhancing the generalizability and applicability of their findings.

Expedited Regulatory Processes

Navigating regulatory processes can often be a time-consuming and complex endeavor for Medtech companies. However, with bioaccess™’s expertise in regulatory affairs, Medtech companies can navigate these processes efficiently, expediting the initiation and execution of their trials and accelerating the overall development timeline of their products.

Advertisement

Cost-Effective Solutions

Conducting clinical trials can be a costly endeavor, with expenses encompassing study design, site selection, patient recruitment, and data collection. Fortunately, bioaccess™ offers cost-effective solutions for Medtech companies seeking to optimize their research budgets. By leveraging bioaccess™’s resources and expertise, Medtech companies can achieve significant cost savings for clinical trials without compromising on quality or compliance.

Access to Experienced Investigators

Successful clinical trials rely on the expertise of skilled investigators who can effectively manage study protocols, recruit patients, and collect accurate data. With bioaccess™’s network of experienced investigators, Medtech companies gain access to individuals with diverse medical backgrounds and research expertise. These investigators are committed to maintaining the highest standards of clinical research conduct, ensuring the success and credibility of Medtech clinical trials.

Ethical Considerations and Patient Safety

Advertisement

Ethical considerations and patient safety are paramount in clinical research. Medtech companies partnering with bioaccess™ can rest assured knowing that their studies are conducted ethically and in compliance with international guidelines, thereby bolstering the credibility and reliability of their findings.

In conclusion, bioaccess™ provides an unparalleled partnership for Medtech companies looking to conduct clinical trials. With its diverse patient populations, expedited regulatory processes, cost-effective solutions, access to experienced investigators, and commitment to ethical considerations and patient safety, bioaccess™ is paving the way for accelerated innovation in the field of medical technology. By partnering with bioaccess™, Medtech companies can expedite the development and commercialization of life-changing medical devices, ultimately benefiting patients worldwide.

Continue Reading

Trending